SCHEMBL3722802

SCHEMBL3722802

N#Cc1cc2c(c(C(F)(F)F)c1)C(O)(c1ccc(Cl)cc1Cl)C(=O)N2CC1CC(N(C2CC2)C2CC2)C1

nearest known ligand 0.48

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 10/20 0.48
CRHR1 P34998 5/20 0.38
TRPV4 Q9HBA0 4/20 0.35
MCHR1 Q99705 1/20 0.32
TRPM8 Q7Z2W7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3729623 1.00 GHSR (0.48) GHSRCRHR1TRPV4MCHR1TRPM8
SCHEMBL3722803 1.00 GHSR (0.48) GHSRCRHR1TRPV4MCHR1TRPM8
SCHEMBL3731703 0.92 GHSR (0.49) GHSRCRHR1TRPV4
SCHEMBL3731706 0.92 GHSR (0.49) GHSRCRHR1TRPV4
SCHEMBL13077352 0.91 GHSR (0.46) GHSRCRHR1TRPV4MCHR1
SCHEMBL13077584 0.91 GHSR (0.46) GHSRCRHR1TRPV4MCHR1
SCHEMBL3728002 0.91 GHSR (0.52) GHSRCRHR1TRPV4
SCHEMBL3728004 0.91 GHSR (0.52) GHSRCRHR1TRPV4
SCHEMBL3729644 0.91 GHSR (0.52) GHSRCRHR1TRPV4
SCHEMBL3736554 0.88 GHSR (0.49) GHSRCRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825155-B2 Oxindole derivative as feeding control agent DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2010-11-02 US disclosed
US-20090131398-A1 OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2009-05-21 US disclosed
EP-1935883-A1 OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT Dainippon Sumitomo Pharma Co., Ltd. (JP) 2008-06-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131398-A1 OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT GPR119, OXTR, CCKAR GHSR 9/4885CRHR1 139/4885TRPV4 4782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.